Global Biologics Safety Testing Market – Size, Outlook, Trends and Forecast (2024 – 2032)

Biologics are products extracted from biological sources such as living organisms, proteins and nucleic acid. Biological safety testing is necessary to ensure product safety, and ensure the quality of biopharmaceutical products which are free from viral pathogens. Global Biologics Safety Testing Market value is projected to be $2.75 Billion in 2017 and is expected to generate revenue of around $6.15 Billion by the end of 2024, growing at a CAGR of around 12.20% between 2017 and 2024. Rise in a number of drug launches and increasing pharmaceutical and biotechnology industries are the factors enhancing the growth of the market. The dearth of skilled professionals are the factors which hamper the market growth.  Emerging markets and rising pharmaceutical outsourcing are the opportunities for biologics testing market.

Research Study Objectives:

• Define, estimate, and forecast the Biologics Safety Testing Market statistics by product and service, application, test type and regions concerning the individual growth drivers, market trends and their contribution toward the Biologics Safety Testing Market growth
• Provides comprehensive information regarding the key factors influencing the market growth (Drivers, Restraints & Challenges, and Opportunities)
• Estimate & forecast the market size of all the segments concerning geographies including North America, Europe, Asia Pacific (APAC), South America and the Middle East and Africa (MEA).
• Recent competitive developments including M&A (Mergers and Acquisitions), Partnerships, and Product Innovations are provided in the Biologics Safety Testing Market analysis report.
• Analysis and conclusions on the future Biologics Safety Testing Market outlook.

Top-down and bottom-up approaches are used to validate the Biologics Safety Testing Market size and are used to estimate the size of other dependent submarkets. Key players in the market are identified through various secondary sources; databases including Bloomberg Businessweek, Hoovers, Factiva, journals and associations and the market revenues are estimated and are thoroughly validated through primary and secondary research. Secondary research involves the study of annual and financial reports of top players in the market, whereas primary research includes extensive interviews with the KoL’s such as CEOs, directors, board members, VP’s, sales managers, engineers, marketing executives, technicians, account managers, investors, strategic decision makers and others. The Biologics Safety Testing Market shares and breakdowns are determined using secondary sources and are verified by the primary sources. All possible parameters/factors that are affecting the Biologics Safety Testing Market demand are covered in the research study are verified through primary research, analysed and interpreted to get the final qualitative and quantitative data. This data is collected and added with detailed analysis from Envision Inteligence and presented in this report.

The scope of the Report

The Biologics Safety Testing Market segmentation is as follows:

By Product and Service 

• Kits & Reagents
• Services
• Instruments

By Test Type

• Endotoxin tests
• Sterility tests
• Cell line authentication and characterisation tests
• Bioburden tests
• Residual host contaminant detection tests
• Adventitious agent detection tests
• Other tests

By Application

• Vaccine & therapeutics development
• Blood and blood-related products testing
• Cellular and gene therapy
• Tissue and tissue-related products testing
• Stem cell research

Geographical Analysis:

Biologics Safety Testing Market is segmented by geography into North America, South America, Europe, APAC and Middle East & Africa. U.S., Canada, Mexico and Costa Rica are analysed under North American region which is usually turning as the hotspot in the market. The South American region is further segregated into Brazil, Argentina, Chile, Columbia and some other emerging economies. In Europe, the market is extensively examined by covering U.K., Germany, France, Italy, Spain, Netherlands, Poland, Switzerland and some other promising economies. APAC is further categorised by countries into China, India, Japan, South Korea, Australia & New Zealand, Malaysia, Singapore and many other emerging nations. In the Middle East & African region, Saudi Arabia, UAE, Iran, Iraq, Qatar, South Africa, Algeria, Morocco, Nigeria and so on countries are evaluated to understand the market growth lucidly.

Customization Options:

With the given research report, Envision Inteligence offers customisations as per the client’s specific requirements. The following customisation options offered for the Biologics Safety Testing Market include:

• Scope Revision
• Geographic Analysis
• Company Profiles
• Historical Data & Forecasting
• Key Contact Persons in companies

Global Biologics Safety Testing Market Research Report Includes:

• An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
• To have a complete market analysis through industry value chain analysis, Porter’s Five Force Model, PESTLE, SWOTanalysis, and Y-o-Y analysis.
• Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
• Identifying DROC in the current market and their impact on altering market dynamics.
• Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
• Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
• Identify the latest developments, market shares and strategies that are employed by the significant Biologics Safety Testing Market players, such as
  • Source Bioscience Company.
  • Lonza Group Ltd.
  • The Merck Group.
  • The Sartorius group.
  • Charles River Laboratories International, Inc.
• Along with these companies, many other companies are considered in the report while analysing the global biologics testing competitive strategies and environment. These companies held substantial share-owning to the nature of the industry whereas, the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players also have considerable presence owing to its robust brand image, geographical reach and stable customer base.